Cortical stimulation induces Fos expression in striatal neurons via NMDA glutamate and dopamine receptors

Cortical electrical stimulation has been shown to induce dense and widespread Fos expression throughout the ipsilateral and contralateral striatum. This raises interest for studying the mechanisms underlying the regulation of striatal neuron activity by cortical afferents, and for elucidating the interactions with other systems. However, the receptors mediating cortical-stimulation-induced expression of Fos in striatal neurons have not been identified. This was studied in the work reported here by stimulating the cortex after administration of glutamate or dopamine receptor antagonists, or after 6-hydroxydopamine (6-OHDA) lesion of the nigrostriatal dopaminergic system. Pretreatment with the non-competitive N-methyl-D-aspartate (NMDA) glutamate receptor antagonist MK-801 led to a marked reduction in the stimulation-induced density of Fos-immunoreactive nuclei in both the medial (about 80% reduction) and lateral (about 50-60% reduction) striatum. Preadministration of the D1-selective dopamine antagonist SCH-23390 alone or in combination with the D2-selective dopamine antagonist eticlopride led to a reduction in the stimulation-induced density of Fos-positive nuclei of about 60-65% in the lateral striatum, but no significant change in the medial region. The effects of 6-OHDA lesion were less pronounced, and the stimulation-induced density of Fos-immunoreactive nuclei decreased by only about 25% in the lateral region. These results indicate that both dopamine and NMDA glutamate receptors are involved in the induction of Fos by cortical stimulation, and support the hypothesis that cortex-dopamine interactions in the lateral striatum may be functionally different from those in the medial striatum.

[1]  H. Fibiger,et al.  D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons , 1992, Neuroscience.

[2]  G. Hanson,et al.  Role of N-methyl-d-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems , 1992, Brain Research.

[3]  J. Mcnamara,et al.  NMDA and non-NMDA receptor-mediated increase of c-fos mRNA in dentate gyrus neurons involves calcium influx via different routes , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[4]  U. Ungerstedt,et al.  Dopamine D1 and D2 receptor antagonism differentially modulates stimulation of striatal neurotransmitter levels by N-methyl-D-aspartic acid. , 1994, European journal of pharmacology.

[5]  A. Parent,et al.  Synaptic relationships between dopaminergic afferents and cortical or thalamic input in the sensorimotor territory of the striatum in monkey , 1994, The Journal of comparative neurology.

[6]  H. Tilson,et al.  Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage , 1988, Brain Research.

[7]  J. Glowinski,et al.  Release of dopamine evoked by electrical stimulation of the motor and visual areas of the cerebral cortex in both caudate nuclei and in the substantia nigra in the cat , 1978, Brain Research.

[8]  L. Fowler,et al.  N-methyl-d-aspartate receptors modulate extracellular dopamine concentration and metabolism in rat hippocampus and striatum in vivo , 1994, Brain Research.

[9]  F. Sharp,et al.  N-methyl-d-aspartate receptor activation in the neostriatum increases c-fos and fos-related antigens selectively in medium-sized neurons , 1991, Neuroscience.

[10]  G. Vincendon,et al.  Dopamine D2 receptor antagonists induce immediate early genes in the rat striatum , 1992, Brain Research Bulletin.

[11]  A. Graybiel,et al.  Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Joyce,et al.  Selective increase of NMDA-sensitive glutamate binding in the striatum of Parkinson's disease, Alzheimer's disease, and mixed Parkinson's disease/Alzheimer's disease patients: an autoradiographic study , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[13]  J. Penney,et al.  Glutamate receptor expression in rat striatum: Effect of deafferentation , 1994, Brain Research.

[14]  J. Joyce,et al.  Dopamine D-2 receptors in rat caudate-putamen: the lateral to medial gradient does not correspond to dopaminergic innervation , 1985, Brain Research.

[15]  R. Rimondini,et al.  The modulation of dopaminergic transmission in the striatum by MK-801 is independent of presynaptic mechanisms , 1992, Neuropharmacology.

[16]  U. Ungerstedt,et al.  Bilateral regulation of glutamate tissue and extracellular levels in caudate-putamen by midbrain dopamine neurons , 1990, Neuroscience Letters.

[17]  A. Lajtha,et al.  NMDA receptors are not involved in the MK-801-induced increase of striatal dopamine release in rat: a microdialysis study , 1994, Brain Research.

[18]  J. Penney,et al.  Glutamate receptors in striatum and substantia nigra: Effects of medial forebrain bundle lesions , 1994, Brain Research.

[19]  P. Roberts,et al.  STIMULATORY EFFECT OF l‐GLUTAMATE AND RELATED AMINO ACIDS ON [3H]DOPAMINE RELEASE FROM RAT STRIATUM: AN IN VITRO MODEL FOR GLUTAMATE ACTIONS , 1979, Journal of neurochemistry.

[20]  F. Fonnum,et al.  Glutamate in cortical fibers. , 1981, Advances in biochemical psychopharmacology.

[21]  G. Chiara,et al.  l-Dopa stimulates c-fos expression in dopamine denervated striatum by combined activation of D-1 and D-2 receptors , 1993, Brain Research.

[22]  B. Bloch,et al.  Fos Immunoreactivity after Stimulation or Inhibition of Muscarinic Receptors Indicates Anatomical Specificity for Cholinergic Control of Striatal Efferent Neurons and Cortical Neurons in the Rat , 1993, The European journal of neuroscience.

[23]  M. Dragunow,et al.  D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons , 1990, Neuroscience.

[24]  J. Marshall,et al.  Elevated NMDA receptors in parkinsonian striatum. , 1992, Neuroreport.

[25]  J. Penney,et al.  The functional anatomy of basal ganglia disorders , 1989, Trends in Neurosciences.

[26]  B. Scatton,et al.  N-methyl-D-aspartate-type receptors mediate striatal 3H-acetylcholine release evoked by excitatory amino acids , 1982, Nature.

[27]  M. Zigmond,et al.  High glutamate concentrations evoke Ca(++)-independent dopamine release from striatal slices: a possible role of reverse dopamine transport. , 1991, The Journal of pharmacology and experimental therapeutics.

[28]  A. D. Smith,et al.  The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones , 1990, Trends in Neurosciences.

[29]  H. Fibiger,et al.  Cortical regulation of acetylcholine release in rat striatum , 1994, Brain Research.

[30]  M. Cuénod,et al.  Glutamate release in vitro from corticostriatal terminals , 1979, Brain Research.

[31]  A. Grace,et al.  Compensatory responses to nigrostriatal bundle injury. Studies with 6-hydroxydopamine in an animal model of parkinsonism. , 1989, Molecular and chemical neuropathology.

[32]  Toshifumi Yamamoto,et al.  Differential effects of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism in freely moving rats , 1989, Brain Research.

[33]  A. Graybiel,et al.  Dopamine and glutamate agonists stimulate neuron-specific expression of Fos-like protein in the striatum. , 1992, Journal of neurophysiology.

[34]  A. Nieoullon,et al.  N-methyl-d-aspartate receptor blockade impairs behavioural performance of rats in a reaction time task: New evidence for glutamatergic-dopaminergic interactions in the striatum , 1994, Neuroscience.

[35]  A. Nieoullon,et al.  Localization of N‐Methyl‐d‐Aspartate Receptors in the Rat Striatum: Effects of Specific Lesions on the [3H]3‐(2‐Carboxypiperazin‐4‐yl)propyl‐1‐Phosphonic Acid Binding , 1990, Journal of neurochemistry.

[36]  A. Björklund,et al.  Prefrontal Corticostriatal Afferents Maintain Increased Enkephalin Gene Expression in the Dopamine‐denervated Rat Striatum , 1994, The European journal of neuroscience.

[37]  A. Carlsson,et al.  Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease , 1990, Trends in Neurosciences.

[38]  S. Hernández,et al.  NMDA receptor mediates dopamine release in the striatum of unanesthetized rats as measured by brain microdialysis , 1992, Brain Research.

[39]  A. Snyder-Keller Striatal C-fos induction by drugs and stress in neonatally dopamine-depleted rats given nigral transplants: Importance of NMDA activation and relevance to sensitization phenomena , 1991, Experimental Neurology.

[40]  M. Kelland,et al.  Behavioral and electrophysiological comparison of ketamine with dizocilpine in the rat , 1993, Physiology & Behavior.

[41]  L. Fowler,et al.  Regional effects of MK-801 on dopamine and its metabolites studied by in vivo microdialysis , 1992, Neuroscience Letters.

[42]  A. Graybiel,et al.  D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[43]  Micaela Morelli,et al.  Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions , 1994, Trends in Neurosciences.

[44]  S. Deutsch,et al.  A "glutamatergic hypothesis" of schizophrenia. Rationale for pharmacotherapy with glycine. , 1989, Clinical neuropharmacology.

[45]  F. Vaccarino,et al.  Differential induction of immediate early genes by excitatory amino acid receptor types in primary cultures of cortical and striatal neurons. , 1992, Brain research. Molecular brain research.

[46]  G. Di Chiara,et al.  Opposite effects of NMDA receptor blockade on dopaminergic D1- and D2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression. , 1992, The Journal of pharmacology and experimental therapeutics.

[47]  J. Labandeira-Garcia,et al.  Cortical stimulation induces fos expression in intrastriatal striatal grafts , 1994, Brain Research.

[48]  E. Scarnati,et al.  Influence of prelimbic and sensorimotor cortices on striatal neurons in the rat: electrophysiological evidence for converging inputs and the effects of 6-OHDA-induced degeneration of the substantia nigra , 1993, Brain Research.

[49]  G. Chiara,et al.  Glutamate as a neurotransmitter , 1981 .

[50]  A. Imperato,et al.  NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus. , 1990, European journal of pharmacology.

[51]  R. M. Beckstead,et al.  Cortical stimulation induces Fos expression in striatal neurons , 1992, Neuroscience.

[52]  A. Grace Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia , 1991, Neuroscience.

[53]  A. Mcgeorge,et al.  The organization of the projection from the cerebral cortex to the striatum in the rat , 1989, Neuroscience.

[54]  W. Low,et al.  Glutamate Uptake Blockade Induces Striatal Dopamine Release in 6-Hydroxydopamine Rats with Intrastriatal Grafts: Evidence for Host Modulation of Transplanted Dopamine Neurons , 1994, Experimental Neurology.

[55]  J. Labandeira-Garcia,et al.  Comparison between normal developing striatum and developing striatal grafts using drug-induced fos expression and neuron-specific enolase immunohistochemistry , 1994, Neuroscience.

[56]  A. Björklund,et al.  Transection of Corticostriatal Afferents Reduces Amphetamine‐ and Apomorphine‐induced Striatal Fos Expression and Turning Behaviour in Unilaterally 6‐Hydroxydopamine‐lesioned Rats , 1993, The European journal of neuroscience.

[57]  S. Young,et al.  Terminal excitability of the corticostriatal pathway. II. Regulation by glutamate receptor stimulation , 1991, Brain Research.

[58]  A. Björklund,et al.  Intrinsic Organization and Connectivity of Intrastriatal Striatal Transplants in Rats as Revealed by DARPP‐32 Immunohistochemistry: Specificity of Connections with the Lesioned Host Brain , 1989, The European journal of neuroscience.

[59]  J. Desce,et al.  l-Glutamate-evoked release of dopamine from synaptosomes of the rat striatum: Involvement of AMPA and N-methyl-d-aspartate receptors , 1992, Neuroscience.

[60]  C. Rivier,et al.  Cocaine-induced expression of striatal c-fos in the rat is inhibited by NMDA receptor antagonists , 1993, Brain Research Bulletin.

[61]  J. Warter,et al.  Behavioural, pharmacological and biochemical effects of acute and chronic administration of ketamine in the rat , 1991, Neuroscience Letters.

[62]  Takao Shimizu,et al.  Ketamine-induced anesthesia involves the N-methyl-d-aspartate receptor-channel complex in mice , 1992, Brain Research.

[63]  C. Wilson,et al.  Anatomical and physiological properties of the cortical and thalamic innervations of neostriatal tissue grafts. , 1990, Progress in brain research.

[64]  G. Reynolds,et al.  Glutamate stimulates dopamine release from cortical and limbic rat brain in vitro. , 1993, European journal of pharmacology.

[65]  H. Fibiger,et al.  Dopaminergic regulation of striatal acetylcholine release: importance of D1 and N-methyl-D-aspartate receptors. , 1991, The Journal of pharmacology and experimental therapeutics.

[66]  J. Penney,et al.  Organization of N‐methyl‐D‐aspartate glutamate receptor gene expression in the basal ganglia of the rat , 1994, The Journal of comparative neurology.

[67]  A. Jayaraman,et al.  Nicotine induced c-fos expression in the striatum is mediated mostly by dopamine D1 receptor and is dependent on NMDA stimulation. , 1994, Brain research. Molecular brain research.

[68]  C. Wilson,et al.  Restoration of the corticostriatal projection in rat neostriatal grafts: electron microscopic analysis , 1989, Neuroscience.

[69]  H. Fibiger,et al.  Electrical Stimulation of the Medial Prefrontal Cortex Increases Dopamine Release in the Striatum , 1993, Neuropsychopharmacology.

[70]  Greg A. Gerhardt,et al.  Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats , 1993, Brain Research.

[71]  R. Roth,et al.  Effect ofl-glutamate on the release of striatal dopamine: in vivo dialysis and electrochemical studies , 1990, Brain Research.

[72]  A. Gobert,et al.  The glutamate-mediated release of dopamine in the rat striatum: Further characterization of the dual excitatory-inhibitory function , 1990, Neuroscience.

[73]  S. Young,et al.  Terminal excitability of the corticostrial pathway. I. Regulation by dopamine receptor stimulation , 1991, Brain Research.

[74]  A. Nieoullon,et al.  Functional interactions between glutamate and dopamine in the rat striatum , 1994, Neurochemistry International.

[75]  A. Björklund,et al.  Development of intrastriatal striatal grafts and their afferent innervation from the host , 1991, Neuroscience.

[76]  T. Curran,et al.  Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. , 1991, Annual review of neuroscience.